Cramer's 'Mad Money Recap': Bristol-Myers' New Look
The company has long-range plans to be more of a pure drug play, Cramer says.
07:49PM 05/05/08
'Mad Money Lightning Round': Waste Management Is Solid
The company is well-run and a solid buy, Cramer says.
07:24PM 05/05/08
TheStreet.com TV Recap: Vaccines Give Merck Booster Shot
Cramer says the company's vaccine business will continue to be a big revenue-generator.
02:50PM 11/02/07
Cramer's 'Mad Money' Recap: Wells Fargo Will Keep
Cramer says this stock will survive the post-nuclear, post-Bernanke market.
08:09PM 08/16/07
Cramer's 'Mad Money Lightning Round': Be in BioMarin
Cramer says the pharmaceutical company is 'smoking.'
07:32PM 08/16/07
Cramer's 'Mad Money' Recap: Spec Medicine
Kinetic Concepts and Micrus Endovascular are Cramer's newest spec ideas. Plus, his game plan for next week.
10:35PM 08/06/07
Cramer's 'Mad Money Lightning Round': Trump Not Looking Rosy
Cramer eats some crow after recommending his friend buddy pal's shares.
10:35PM 08/06/07
Cramer's 'Mad Money' Recap: The Next Great Diagnostics Play
It's Cepheid, a small company in the running for a big government contract.
01:24AM 06/20/07
Cramer's 'Mad Money' Recap: Citigroup Should Split
Cramer says that right now the company is worth less than the sum of its parts.
07:45PM 06/04/07
Ignore 'Narrow Market' Nonsense (RealMoney.com $)
The trick is that the focus group is different every day. That's classic great rotation.
03:54PM 05/07/07
Cramer's 'Mad Money' Recap: Fed Stranglehold
To help offset the Fed's 'intransigence,' Cramer offers his 'Three Bs' defensive portfolio.
10:04PM 05/02/07
Cramer's 'Mad Money' Recap: Green Market
Cramer says that a landmark Supreme Court decision means it's easier for investors to be green.
07:58PM 04/16/07
Cramer's 'Mad Money' Recap: Homeland Securities
Cramer offers a portfolio as protection in the event of terrorism.
06:58PM 07/21/05
'RealMoney' Radio Wrap-up: Security Stocks
Cramer lays out a strategy to terror-proof your portfolio.
04:27PM 07/21/05


Connect with TheStreet